Power Law company profile

Sana Biotechnology

Biotech & Life Sciences · Seattle, United States · Founded 2018 · IPO 2021 Unicorn

Focused on creating and delivering engineered cells as medicines for patients

Valuation

$829M

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on Sana Biotechnology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage

Flagship Pioneering

Bradley Horowitz

ARCH Venture Partners

F-Prime

Series A 7 investors entered at this stage

Altitude Life Science Ventures

Alaska Permanent Fund

Omega Funds

Bezos Expeditions

PSP Investments

Baillie Gifford

CPP Investments

Series B+ 1 investor entered at this stage

Harvard University

Sana Biotechnology mafia

Startups founded by Sana Biotechnology alumni

Former Sana Biotechnology employees who went on to start their own companies. Sorted by Dealroom signal score.

Apriori BioEst. 2020

Noubar AfeyanUnited States

Signal score66

ResilienceEst. 2020

PYPatrick Y. YangUnited States

Signal score64

Tessera TherapeuticsEst. 2018

Jacob Rubens.United States

Signal score64

Clade TherapeuticsEst. 2020

Chad CowanUnited States

Signal score62

Book a demo to explore the full alumni network →

Global footprint

Where Sana Biotechnology has talent and traffic

AI talent share

0.4% of workforce is AI talent
(1 of 261 staff)

Core AI00%

Other AI10.38%

Non-AI workforce26099.62%

Workforce by country

7 countries with
team presence

🇺🇸 United States96.3%

🇮🇳 India1.2%

🇨🇾 Cyprus0.6%

🇮🇷 Iran0.6%

🇻🇳 Vietnam0.6%

Top 5 of 7 shown

Web traffic by country

28K monthly visits
across markets

🇺🇸 United States62.5%

🇨🇦 Canada7.9%

🇬🇧 United Kingdom6.1%

🇯🇵 Japan5.7%

🇮🇳 India5.4%

Top 5 markets shown

Patent intelligence

$10M patent portfolio · 60 active families

Estimated portfolio value

$10M

1.2% of market cap · 196.5× smaller than top peer Ablynx ($2B)

60 active patent families

Where Sana Biotechnology innovates Molecular biologyViral vectorCell biologyCD47Bioinformatics

Where Sana Biotechnology concentrates vs peers

Each axis is a top-10 topic across Sana Biotechnology and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Sana Biotechnology

An AI-synthesized read of the highest-engagement posts about Sana Biotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sana Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles